← Evidence map

ArticleCancer discovery2018

Myeloproliferative Neoplasms May Be Sensitive to Dual BET/JAK Inhibition.

PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 29305495